These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. Takano T, Clish CB, Gronert K, Petasis N, Serhan CN. J Clin Invest; 1998 Feb 15; 101(4):819-26. PubMed ID: 9466977 [Abstract] [Full Text] [Related]
3. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN. Am J Pathol; 2001 Jan 15; 158(1):3-9. PubMed ID: 11141472 [Abstract] [Full Text] [Related]
4. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. Hachicha M, Pouliot M, Petasis NA, Serhan CN. J Exp Med; 1999 Jun 21; 189(12):1923-30. PubMed ID: 10377187 [Abstract] [Full Text] [Related]
5. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. Devchand PR, Arita M, Hong S, Bannenberg G, Moussignac RL, Gronert K, Serhan CN. FASEB J; 2003 Apr 21; 17(6):652-9. PubMed ID: 12665478 [Abstract] [Full Text] [Related]
6. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN. J Immunol; 2003 Mar 01; 170(5):2688-94. PubMed ID: 12594298 [Abstract] [Full Text] [Related]
7. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. Chiang N, Fierro IM, Gronert K, Serhan CN. J Exp Med; 2000 Apr 03; 191(7):1197-208. PubMed ID: 10748237 [Abstract] [Full Text] [Related]
8. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. Chiang N, Takano T, Clish CB, Petasis NA, Tai HH, Serhan CN. J Pharmacol Exp Ther; 1998 Nov 03; 287(2):779-90. PubMed ID: 9808710 [Abstract] [Full Text] [Related]
9. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side. Serhan CN. Arch Immunol Ther Exp (Warsz); 2001 Nov 03; 49(3):177-88. PubMed ID: 11478391 [Abstract] [Full Text] [Related]
10. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN. J Exp Med; 1997 May 05; 185(9):1693-704. PubMed ID: 9151906 [Abstract] [Full Text] [Related]
11. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. Pouliot M, Serhan CN. J Periodontal Res; 1999 Oct 05; 34(7):370-3. PubMed ID: 10685363 [Abstract] [Full Text] [Related]
12. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. Papayianni A, Serhan CN, Brady HR. J Immunol; 1996 Mar 15; 156(6):2264-72. PubMed ID: 8690917 [Abstract] [Full Text] [Related]
13. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Serhan CN. Prostaglandins; 1997 Feb 15; 53(2):107-37. PubMed ID: 9112289 [Abstract] [Full Text] [Related]
14. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. Qiu FH, Devchand PR, Wada K, Serhan CN. FASEB J; 2001 Dec 15; 15(14):2736-8. PubMed ID: 11687510 [Abstract] [Full Text] [Related]
15. Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. Clària J, Titos E, Jiménez W, Ros J, Ginès P, Arroyo V, Rivera F, Rodés J. Gastroenterology; 1998 Jul 15; 115(1):147-56. PubMed ID: 9649470 [Abstract] [Full Text] [Related]
16. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Clària J, Lee MH, Serhan CN. Mol Med; 1996 Sep 15; 2(5):583-96. PubMed ID: 8898374 [Abstract] [Full Text] [Related]
18. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN. Biochemistry; 2000 Apr 25; 39(16):4761-8. PubMed ID: 10769133 [Abstract] [Full Text] [Related]
19. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Chiang N, Arita M, Serhan CN. Prostaglandins Leukot Essent Fatty Acids; 2005 Apr 25; 73(3-4):163-77. PubMed ID: 16125378 [Abstract] [Full Text] [Related]
20. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. Fiorucci S, Distrutti E, de Lima OM, Romano M, Mencarelli A, Barbanti M, Palazzini E, Morelli A, Wallace JL. FASEB J; 2003 Jun 25; 17(9):1171-3. PubMed ID: 12709408 [Abstract] [Full Text] [Related] Page: [Next] [New Search]